Abstract
A bacitracin (0.04 units, BBL)-SXT (trimethoprim, 1.25 mg, plus sulfamethoxazole, 23.75 mg, BBL) susceptibility test was 94% accurate in presumptively identifying streptococci as either group A, B or not group A and B.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dajani A. S. Rapid identification of beta hemolytic streptococci by counterimmunoelectrophoresis. J Immunol. 1973 Jun;110(6):1702–1705. [PubMed] [Google Scholar]
- Edwards E. A., Larson G. L. Serological grouping of hemolytic streptococci by counter-immunoelectrophoresis. Appl Microbiol. 1973 Dec;26(6):899–903. doi: 10.1128/am.26.6.899-903.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Facklam R. R. Comparison of several laboratory media for presumptive identification of enterococci and group D streptococci. Appl Microbiol. 1973 Aug;26(2):138–145. doi: 10.1128/am.26.2.138-145.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Koch A. E., Burchall J. J. Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media. Appl Microbiol. 1971 Nov;22(5):812–817. doi: 10.1128/am.22.5.812-817.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]